Cherry-picked trials are empirically worthless - they are not better than no trials at all. Since drug companies need to submit drug trials to get through appr

Cherry-picked trials are empirically worthless - they are not better than no trials at all. Since drug companies need to submit drug trials to get through approval, it is hard to see how the result of such a rule could worsen the evidence we get.